Why the study?
Although obesity reduces short-term mortality in sepsis, the main subgroups and the role of immune-related inflammatory status require further research.
Does BMI affect 28-day mortality in patients with sepsis?
Does BMI affect 28-day mortality in patients with sepsis?
In sepsis patients, particularly elderly males without septic shock, BMI exhibits a U-shaped relationship with 28-day mortality, potentially mediated by immune-inflammatory status.
Obesity-associated survival benefit appears limited to elderly males without shock; leaves open causal immune-inflammatory mechanisms and need for targeted trials.
BACKGROUND: Obesity has been shown to reduce short-term mortality in sepsis patients, but the main subgroups and its role in immune-related inflammatory status require further research. The aim of this study was to identify the primary beneficiaries of the sepsis-obesity paradox and to investigate the involvement of immune-inflammatory status. METHODS: In this study, we analyzed data from 6602 sepsis patients from the MIMIC-IV database. Body mass index (BMI) was divided into quartiles, and mortality rates were assessed for each interval. Logistic trend tests and subgroup and restricted cubic spline (RCS) analyses were performed. Blood biochemical indicators were compared across different BMI ranges and between survivors and non-survivors. The receiver operating characteristic (ROC) curve for 28-day mortality was also evaluated. RESULTS: , respectively. CONCLUSIONS: The sepsis-obesity paradox significantly affects elderly (≥ 65 years old), male, and non-septic shock individuals, displaying a U-shaped pattern for 28-day mortality. BMI may mediate this phenomenon by influencing the body's immune-inflammatory status.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: